- 1) Matoba, N., Usui, H., Fujita, H., and Yoshikawa, M., A novel anti-hypertensive peptide derived from ovalbumin induces nitric oxide-mediated vasorelaxation in an isolated SHR mesenteric artery. FEBS Lett., 452, 181–184 (1999).
- 2) Yamada, Y., Matoba, N., Usui, H., Onishi, K., and Yoshikawa, M., Design of a highly potent anti-hypertensive peptide based on ovokinin(2–7). Biosci. Biotechnol. Biochem., 66, 1213–1217 (2002).
- 3) Momma, T., Negoro, T., Hirano, H., Matsumoto, A., Udaka, K., and Fukazawa, C., Glycinin A5A4B3 mRNA: cDNA cloning and nucleotide sequencing of a splitting storage protein subunit of soybean. Eur. J. Biochem., 149, 491–496 (1985).
- 4) Yoshikawa, M., Yamamoto, T., and Takenaka, Y., Study on a low molecular weight peptide derived from soybean protein having hypocholesterolemic activity. Soy Protein Research Japan (in Japanese), 2, 125–128 (1999).
- 5) Yoshikawa, M., and Sonoda, S., Studies on interaction between soy constituents and central nervous system. Soy Protein Research Japan (in Japanese), 7, 75–78 (2004).
- 6) Yang, S., Yunden, J., Sonoda, S., Doyama, N., Lipkowski, A. W., Kawamura, Y., and Yoshikawa, M., Rubiscolin, a δ selective opioid peptide derived from plant Rubisco. FEBS Lett., 509, 213–217 (2001).
- 7) Yang, S., Kawamura, Y., and Yoshikawa, M., Effect of rubiscolin, a δ opioid peptide derived from Rubisco, on memory consolidation. Peptides, 24, 325–328 (2003).
- 8) Hirata, H., Sonoda, S., Agui, S., Yoshida, M., Ohinata, K., and Yoshikawa, M., Rubiscolin-6, a δ opioid peptide derived from spinach Rubisco, has anxiolytic effect via activating σ1 and dopamine D1 receptors. Peptides, 28, 1998–2003 (2007).
- 9) Onishi, K., Matoba, N., Yamada, Y., Doyama, N., Maruyama, N., Utsumi, S., and Yoshikawa, M., Optimal designing of β-conglycinin to genetically incorporate RPLKPW, a potent anti-hypertensive peptide. Peptides, 25, 37–43 (2004).
- 10) Yamada, Y., Nishizawa, K., Yokoo, M., Hui, X., Onishi, K., Teraishi, M., Utsumi, S., Ishimoto, M., and Yoshikawa, M., Anti-hypertensive activity of genetically modified soybean seeds accumulating novokinin. Peptides, 29, 331–337 (2008).
- 11) Maruyama, N., Katsube, T., Wada, Y., Oh, M. H., Barba De La Rosa, A. P., Okuda, E., Nakagawa, S., and Utsumi, S., The roles of the N-linked glycans and extension regions of soybean β-conglycinin in folding, assembly and structural features. Eur. J. Biochem., 258, 854–862 (1998).
- 12) Khalafalla, M. M., Rhaman, S. M., El-Shemy, H. A., Nakamoto, Y., Wakasa, K., and Ishimoto, M., Optimization of particle bombardment conditions by monitoring of transient sGFP(S65T) expression in transformed soybean. Breed. Sci., 55, 257–263 (2005).
- 13) Takagi, H., Saito, S., Yang, L., Nagasaka, S., Nishizawa, N., and Takaiwa, F., Oral immunotherapy against a pollen allergy using a seed-based peptide vaccine. Plant Biotechnol. J., 3, 521–533 (2005).
- 14) Takaiwa, F., Takagi, H., Hirose, S., and Wakasa, Y., Endosperm tissue is good production platform for artificial recombinant proteins in transgenic rice. Plant Biotechnol. J., 5, 84–92 (2007).
Bioscience, Biotechnology, and Biochemistry
Volume 72, 2008 - Issue 12